Tenderwize
Back to tender search

Open House Drug Rebate Agreements Lamotrigine, ATC N03AX09

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 05, 2027 · 231 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Lamotrigin, ATC N03AX09

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

Open-house model provides no exclusivity; other buyers may have separate contracts. This may limit demand.

Administrative burden of paper submission (two originals) or requiring qualified electronic signature.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing Lamotrigine (ATC N03AX09)
  • Non-exclusive rebate agreement under §130a Abs. 8 SGB V
Show full summary

Open-house model for non-exclusive drug rebate agreements for Lamotrigine (ATC N03AX09) with AOK Bayern. All eligible pharmaceutical companies can join. No competitive selection; contracts are identical and non-negotiable. Duration: 01.06.2025 to 31.05.2027. Applications accepted until 05.04.2027. No estimated value published.

Risks

Open-house model provides no exclusivity; other buyers may have separate contracts. This may limit demand.

Administrative burden of paper submission (two originals) or requiring qualified electronic signature.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' required.

Eligibility

  • Only pharmaceutical companies are eligible.

Administrative

  • Must submit signed self-declaration of reliability.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open House Drug Rebate Agreements Lamotrigine, ATC N03AX09

Non-exclusive rebate agreements for the active substance Lamotrigine. All interested pharmaceutical companies meeting eligibility criteria may sign identical contracts. The contract start is flexible (earliest 01.06.2025) and ends 31.05.2027.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline Apr 05, 2027

Procurement Details

Publication date
15 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
247124-2025

Documents (2)

Similar tenders